首页> 外文期刊>Bone marrow transplantation >Successful engraftment following umbilical cord blood transplantation for patients with HLA antibody with or without corresponding HLA in the transplanted cord blood.
【24h】

Successful engraftment following umbilical cord blood transplantation for patients with HLA antibody with or without corresponding HLA in the transplanted cord blood.

机译:脐带血移植后成功移植的脐带血中有或没有相应HLA的HLA抗体患者。

获取原文
获取原文并翻译 | 示例
       

摘要

Umbilical cord blood transplantation (CBT) from unrelated donors has increased recently for adult patients with hematological diseases who have no other suitable related or unrelated donors, as cord blood (CB) shows clinical characteristics, such as greater availability, shorter time for donor searches and less stringent requirements for HLA compatibility. However, primary graft failure or delayed neutrophil recovery are often encountered as significant problems. As the existence of HLA antibody has been thought to increase the risk of graft failure, patients with HLA antibodies may be excluded as candidates for CBT. Such patients also tend to be excluded as candidates for CBT because of the need for HLA-matched platelet transfusion. However, few reports have described the practical impact of HLA antibody in CBT. Here, we report two cases of successful engraft-ment following CBT for patients with HLA antibodies (Table 1).
机译:对于没有其他合适相关或不相关供体的血液病成年患者,近来来自无关供体的脐带血移植(CBT)有所增加,因为脐带血(CB)显示出临床特征,例如可用性更高,寻找供体的时间更短以及对HLA兼容性的要求不那么严格。然而,原发性移植物衰竭或中性粒细胞恢复延迟通常是严重的问题。由于人们认为HLA抗体的存在会增加移植失败的风险,因此可能会将HLA抗体患者排除为CBT候选者。由于需要HLA匹配的血小板输注,此类患者也倾向于被排除为CBT候选者。但是,很少有报道描述HLA抗体对CBT的实际影响。在这里,我们报告了CLA后HLA抗体患者成功植入两个案例(表1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号